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Healthcare workers (HCWs) are at high risk of COVID-19 infection, 
with 22 073 cases in HCWs from 52 countries reported to the World 
Health Organization (WHO) by early April 2020.[1,2] Continuous 
availability of personal protective equipment (PPE), correct PPE 
application/removal and appropriate decontamination of re-usable 
PPE are key to protecting HCWs from infectious pathogens, 
including COVID-19.
The current pandemic has challenged PPE supply chains globally 
and necessitated rapid review of the scientific evidence for PPE use 
and re-use. Both the WHO and the US Centers for Disease Control 
and Prevention have updated their guidance on PPE preservation 
strategies in the face of critical shortages.[3-6] As South African (SA) 
healthcare facilities develop contingency plans for expected PPE 
shortages, the following tiered PPE preservation strategies should be 
considered: 
• Restricted use: use PPE as recommended in the national infection 
prevention guidelines,[7] minimise access of visitors to healthcare 
facilities, cohort staff to COVID high- v. low-risk areas, and limit 
the number of staff performing aerosol-generating procedures, e.g. 
one staff member performs COVID-19 testing.
• Extended use: use PPE for longer periods of time than normally 
recommended and/or while caring for several different patients 
without removal, e.g. visors and surgical masks.
• Procurement of alternative or emergency replacement PPE, e.g. 
3D printed face shields, and plastic rain ponchos or refuse bags to 
replace aprons.
• Use of PPE after the manufacturer-designated shelf-life, e.g. use of 
masks after the expiry date.
• Procurement of re-usable PPE, e.g. goggles or re-usable plastic 
visors instead of disposable visors.
• Re-use of PPE: this involves the decontamination of PPE items that 
would normally be disposed of after use (single-use items), e.g. N95 
respirators. Re-use should only be considered as a last resort when 
PPE supplies are about to run out and there are no alternatives 
available. Re-use of PPE in COVID-19 critical care settings should 
be avoided owing to increased risk of HCW infection.
In SA, where the COVID-19 epidemic is still developing, healthcare 
facilities have a short window of opportunity to improve PPE supply 
chains, train staff on prudent PPE use, and devise plans to track and 
manage the inevitable increases in PPE demand. Restricted use of PPE 
should be implemented in all facilities. This effort would be aided by 
the use of non-medical (cloth) masks for visitors and administrative 
staff,[8,9] and preserving medical masks for frontline workers.
For public sector SA HCWs exposed to tuberculosis, extended 
use of N95 respirators is already practised, with continuous use 
over 1 day or intermittent use over 1 week, if respirator integrity 
and the seal is maintained. This extended-use policy applies to 
COVID-19, with the same caveats of respirator integrity, an intact 
seal, appropriate storage (labelled paper bag or envelope), and 
thorough hand hygiene when donning and removing the respirator. 
Respirators should not be shared between HCWs.[3,6] Surgical mask 
use can be extended to a single shift, particularly for HCWs with 
minimal close patient contact. Most face shields, visors and goggles 
are suitable for re-use following careful decontamination (soap and 
water cleaning, followed by disinfection with 70% alcohol). Re-usable 
face shields are preferable to goggles and disposable shields as they 
reduce droplet contamination of the mask/respirator. For COVID-19 
intensive care wards, extended use of gowns for the duration of the 
shift is permissible. Aprons should preferably be changed between 
patient care activities, especially when contaminated with respiratory 
secretions or body fluids; aprons are not suitable for re-use. Gloves 
cannot be re-used and should be changed between each patient 
contact, followed by thorough hand hygiene.[3]
There is a limited evidence base to guide methods for 
decontamination of N95 respirators, although new data are rapidly 
emerging and commercial systems are being developed.[10-12] 
Decontamination of N95 respirators should only be considered 
This open-access article is distributed under 
Creative Commons licence CC-BY-NC 4.0.
ISSUES IN MEDICINE 
Personal protective equipment (PPE) in a pandemic: 
Approaches to PPE preservation for South African 
healthcare facilities
C le Roux,1 MB ChB, student intern; A Dramowski,2 MB ChB, FC Paed (SA), MMed (Paed), Cert ID (SA) Paed, DCH, PhD
1 Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
2  Division of Paediatric Infectious Diseases, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences,  
Stellenbosch University, Cape Town, South Africa
Corresponding author: A Dramowski (dramowski@sun.ac.za)
Personal protective equipment (PPE) is key to protecting healthcare workers from COVID-19 infection, but the pandemic has disrupted 
supply chains globally and necessitated rapid review of the scientific evidence for PPE re-use. In South Africa, where the COVID-19 
epidemic is still developing, healthcare facilities have a short window of opportunity to improve PPE supply chains, train staff on prudent 
PPE use, and devise plans to track and manage the inevitable increases in PPE demand. This article discusses the available PPE preservation 
strategies and addresses the issue of decontamination and re-use of N95 respirators as a last-resort strategy for critical shortages during the 
pandemic.
S Afr Med J. Published online 30 April 2020. https://doi.org/10.7196/SAMJ.2020.v110i6.14831
       Published online ahead of print
IN PRACTICE
as a last resort to ensure a supply of N95 respirators for HCWs 
performing aerosol-generating procedures on patients with 
suspected/confirmed COVID-19. Problems with respirator re-use 
following decontamination include an inadequate seal (following 
wear or damage to the elastic straps), damage to the integrity of 
filter fibres, and lack of local testing to verify virus and particle 
filtration efficiency after respirator processing.[5,6] In most low-
resource settings, N95 respirator decontamination is unlikely to be 
feasible or affordable, and it is at best a stop-gap approach until a 
supply of new respirators is assured. Should SA healthcare facilities 
embark on N95 respirator decontamination programmes, the costs, 
feasibility, reproducibility and safety of the available methods should 
be carefully considered (Table 1).
An urgent and critical review of healthcare facility PPE supply 
and preservation strategies should be undertaken at every SA 
healthcare facility, incorporating national and international 
recommendations. [3-4,7] Restricted use, extended use, procurement 
of re-usable PPE and development of alternative PPE items should 
remain the focus of local PPE preservation activities. However, 
decontamination to enable re-use of N95 respirators could be a last 
resort strategy for critical shortages during the pandemic. Current 
obstacles to implementing N95 respirator decontamination in SA 
and other low-resource settings are the substantial financial costs 
and lack of available technology for rapid implementation. Given the 
heightened risk of COVID-19 infection in HCWs and potential PPE 
shortages, SA healthcare facilities should actively implement PPE 
preservation approaches and consider options for N95 respirator 
decontamination should a supply crisis occur. 
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Table 1. Methods for reprocessing of N95 respirators during critical shortages
Disinfection 
method
Equipment requirements, processing 
time and volume* Advantages and disadvantages
Hydrogen peroxide 
vapour
• Hydrogen peroxide vapour generator, 
e.g. Sterrad or Bioquell Clarus[3]
• A sealed chamber
• 8-hour processing time, including 
conditioning, gassing, dwell and 
aeration phases[10] 
• Respirator performance maintained for 10 re-uses.[3,10,11]
• Large-volume processing is possible.[12]
• Allows for even penetration of vapour over entire respirator, as opposed to 
UVGI, where there may be a shadow effect on some respirator surfaces.[5]
• Currently the most cost-effective from of gas sterilisation,[13] with low 
toxicity.[10,14]
• Carcinogenic, but safe for use following an aeration period; can cause eye 
damage if in contact.[15]
• Not compatible with material containing celluloses.
• Respirator straps may absorb hydrogen peroxide, causing low vapour 
concentration and aborted cycle.[14]
UVGI • A UV-C lamp emitting a minimum 
effective dose of 1.8 J/cm2
• A reflective chamber or box[3,5]
• 15-minute exposure time for each side 
of the respirator[3,14,16]
• UVGI application does not affect filtration performance,[3,5,16], but may cause 
elastic strap degradation. Avoid dose >950 J/cm.[2]
• Respirator fit must be assessed following UVGI; 90 - 100% correct fit after 
three cycles, depending on respirator type.
• A shadow effect (UV light not reaching within folds of respirators) can occur, 
with incomplete decontamination.[5,17]
• Precautions taken to avoid UVGI exposure to eyes and skin.[5]
Microwave-
generated steam
• Microwave (>1 100 watts)
• Microwave steam bags (for sterilisation 
of formula bottles)
• Run at a minimum of 1 100 watts for 
90 seconds in a bag filled with 60 mL 
tap water[5,11]
• Microwaves are widely available, but the method is limited to processing a 
single respirator at a time.
• Has potential to rapidly decontaminate a respirator in the clinical area as 
needed.
• Metal strip in respirators can cause sparks in the microwave.




owing to limited 
evidence
• Moist heat incubation: currently not recommended owing to limited evidence of efficacy of killing various pathogens.[ 5,17] 
Incubation temperature of 65°C at 85% relative humidity for 30 minutes.[3,5]
• Mask rotation: each HCW has a set number of respirators that they rotate use of. Respirators are dried for >72 hours, 
whereafter virus is no longer viable and the respirator can be re-used.[17]
• Ozone: requires an ozone generator and a sealed box or chamber.[18] Very limited scientific literature. Toxic in high 
concentrations. Need for aeration time.[18-21]
• Other methods not recommended either owing to lack of evidence of efficacy or damage to the respirator include: 
liquid hydrogen peroxide/hydrogen peroxide plasma; dry heat; 70% isopropyl alcohol; autoclave; soap; dry microwave 
irradiation; gamma irradiation; bleach.[3,5,11,14-18] Ethylene oxide is not recommended as it may harm the wearer, among 
other reasons.[3,5,13,15,22]
UVGI = ultraviolet germicidal irradiation; HCW = healthcare worker.
*For most methods, the volume of N95 respirators that can be processed in a single cycle is determined by the chamber size.
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